PiaSky® (crovalimab-akkz)
for Paroxysmal Nocturnal Hemoglobinuria
PiaSky (crovalimab-akkz) is used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adults and teenagers. Administered once every 4 weeks after a loading dose, PiaSky can be given by subcutaneous or intravenous injection. It works by targeting the complement system, specifically binding to complement protein C5, preventing the formation of a complex that causes red blood cell destruction. This helps protect red blood cells from damage in PNH patients.